Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adderall-XR for Cannabis Use Disorder with Comorbid ADHD
NCT02803229Phase 3Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Jul 2016
- Primary completion
- Jun 2020
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of adderall xr in cannabis use disorder (CUD), attention deficit hyperactivity disorder (ADHD), sponsored by New York State Psychiatric Institute. Started Jul 2016; status: completed.
02
Drugs
adderall xr
03
Conditions
cannabis use disorder (CUD)attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02803229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02803229.